2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Purity ≥98.0% (HPLC)

Whakaahuatanga Poto:

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene

CAS: 1030825-20-7

Te ahua: Paura Ma, Paura-White ranei

Maamaa: ≥98.0% (HPLC)

Takawaenga o te API (CAS: 842133-18-0) i roto i te maimoatanga o te Momo 2 Diabetes Mellitus

Inquiry: alvin@ruifuchem.com

Tukuna he imeera ki a matou

Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Kaihanga Kaihanga Kaihanga Takawaenga:
4-Wakawa Fluorophenylboronic CAS: 1765-93-1
2-(4-Fluorophenyl)thiophene CAS: 58861-48-6
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9
5-Iodo-2-Methylbenzoic Waikawa CAS 54811-38-0
2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl] tiophene CAS: 898566-17-1
CAS: 842133-18-0
CAS: 928672-86-0

Nga Ahuatanga matū:

Ingoa matū	2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
Tau CAS	1030825-20-7
Tau CAT	RF-PI234
Tūnga Taonga	Kei roto i nga taonga, ka eke ki te rau kirokaramu
Tātai rāpoi	C18H14BrFS
Taumaha rāpoi	361.27
Te Whakarewa	103℃
Kiato	1.388
Waitohu	Ruifu Chemical

Whakatakotoranga:

Tūemi	Whakatakotoranga
Te ahua	Paura Ma, Paura-Ma ranei
Te Maama / Tikanga Tatauria	≥98.0% (HPLC)
Ngaronga i te whakamaroke	≤1.00%
Te toenga i runga i te mura	≤0.50%
Nga Korewa Taamaha	≤20ppm
Paerewa Whakamatau	Paerewa hinonga
Whakamahinga	Takawaenga o API (CAS: 842133-18-0)

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku

Painga:

FAQ:

Taupānga:

Ko Shanghai Ruifu Chemical Co., Ltd. te kaihanga matua me te kaiwhakarato o 2-(5-Bromo-2-Methylbenzyl) -5-(4-Fluorophenyl) thiophene (CAS: 1030825-20-7) me te kounga teitei.Kohe takawaenga i te nuinga o te wa i te whakahiatotanga o te API (CAS: 461432-26-8).Ko te API (CAS: 461432-26-8) he rongoa antidiabetic hou i whakawhanakehia e Bristol-Myers Squibb me AstraZeneca, i whakaaetia e te European Medicines Agency (EMA) i te Noema 12, 2012. Koia hoki te aukati SGLT2 tuatahi mo te te maimoatanga o te mate huka momo II, he mea nui mo te maimoatanga o te mate huka, ka whakamahia hei whakapai ake i te mana glycemic hei taapiri mo te kai me te korikori tinana mo nga pakeke e mate huka momo II.